Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
All content for Few & Far Between: How Biotech Gets Built is the property of Chris O'Brien and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio
Few & Far Between: How Biotech Gets Built
55 minutes 5 seconds
9 months ago
Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio
How do you turn back the epigenetic clock for humans and their animal companions?
Host Chris O'Brien welcomes Dan Oliver, CEO and Founder of Rejuvenate Bio, to the podcast. Tune in as we take a deep dive into parallel clinical trials designed to address chronic, age-related diseases in people and their pets. Plus, we'll zoom in on the right corporate structure for biotech products and the benefits of brainstorming.
Listen in to the latest episode of the Few & Far Between podcast today!
Few & Far Between: How Biotech Gets Built
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
